DOI QR코드

DOI QR Code

Laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer in patients with radical subtotal gastrectomy for gastric cancer

  • Kang Hee Lee (Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine) ;
  • Seung Soo Hong (Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine) ;
  • Seung-seob Kim (Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine) ;
  • Ho Kyoung Hwang (Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine) ;
  • Woo Jung Lee (Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine) ;
  • Chang Moo Kang (Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine)
  • 투고 : 2022.03.07
  • 심사 : 2022.06.08
  • 발행 : 2022.11.30

초록

After radical subtotal gastrectomy (RSTG) for stomach cancer, the remnant stomach is supposed to be perfused through the short gastric vessels. What if a patient who received previous RSTG is diagnosed with resectable distal pancreatic cancer? Can radical distal pancreatosplenectomy (DPS) be performed safely without ischemic damage to the remnant stomach? Unfortunately, there are limited studies on this specific clinical issue. Notably, in spite of rare clinical presentation, it is expected to increase due to prolonged survival of patients with resected gastric cancer. Therefore, we aimed to demonstrate the safety and feasibility of the radical DPS in patients with previous RSTG. In this study, we investigated perioperative and long-term survival outcomes of DPS for left-sided pancreatic cancer in patients with previous RSTG.

키워드

참고문헌

  1. Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 2019;10:10-27. 
  2. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet 2011;378:607-620. 
  3. Luo J, Xiao L, Wu C, Zheng Y, Zhao N. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004-2009. PLoS One 2013;8:e76052. Erratum in: PLoS One 2014;9. 
  4. McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2018;24:4846-4861. 
  5. Moekotte AL, Rawashdeh A, Asbun HJ, Coimbra FJ, Edil BH, Jarufe N, et al. Safe implementation of minimally invasive pancreas resection: a systematic review. HPB (Oxford) 2020;22:637-648. 
  6. de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, et al. Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial. Ann Surg 2019;269:2-9. 
  7. Korrel M, Vissers FL, van Hilst J, de Rooij T, Dijkgraaf MG, Festen S, et al. Minimally invasive versus open distal pancreatectomy: an individual patient data meta-analysis of two randomized controlled trials. HPB (Oxford) 2021;23:323-330. 
  8. Ko KP. Epidemiology of gastric cancer in Korea. J Korean Med Assoc 2019;62:398-406. 
  9. Hong SS, Hwang HK, Lee WJ, Kang CM. Feasibility and safety of laparoscopic radical distal pancreatosplenectomy with adrenalectomy in advanced pancreatic cancer. Ann Surg Oncol 2020;27:5235-5236. 
  10. Kang CM. ASO author reflections: from concept to real clinical practice of laparoscopic distal pancreatectomy for left-sided pancreatic cancer. Ann Surg Oncol 2020;27:5237-5238. 
  11. Chong JU, Kim SH, Hwang HK, Kang CM, Lee WJ. Yonsei criteria: a clinical reflection of stage I left-sided pancreatic cancer. Oncotarget 2017;8:110830-110836. 
  12. Lee SH, Kang CM, Hwang HK, Choi SH, Lee WJ, Chi HS. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Surg Endosc 2014;28:2848-2855. 
  13. Kim CY, Lee SH, Jeon HM, Kim HK, Kang CM, Lee WJ. AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer. Korean J Hepatobiliary Pancreat Surg 2014;18:33-37. 
  14. Lee D, Lee JH, Choi D, Kang CM, Chong JU, Kim SC, et al. Surgical strategy and outcome in patients undergoing pancreaticoduodenectomy after gastric resection: a three-center experience with 39 patients. World J Surg 2017;41:552-558. 
  15. Fukuta M, Tomibayashi A, Tsuneki T, Nishioka K, Matsuo Y, Mori O, et al. Pancreaticoduodenectomy after distal gastrectomy: a case series. Int J Surg Case Rep 2020;76:240-246. 
  16. Kim SH, Hwang HK, Kang CM, Lee WJ. Pancreatoduodenectomy in patients with periampullary cancer after radical subtotal gastrectomy for gastric cancer. Am Surg 2012;78:E164-E167. 
  17. Kawasaki Y, Hwang HK, Kang CM, Natsugoe S, Lee WJ. Improved perioperative outcomes of laparoscopic distal pancreatosplenectomy: modified lasso technique. ANZ J Surg 2018;88:886-890. 
  18. De Nardi P, Elmore U, Maggi G, Maggiore R, Boni L, Cassinotti E, et al. Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial. Surg Endosc 2020;34:53-60. 
  19. Abdelwahab M, Spataro EA, Kandathil CK, Most SP. Neovascularization perfusion of melolabial flaps using intraoperative indocyanine green angiography. JAMA Facial Plast Surg 2019;21:230-236. 
  20. Asari S, Toyama H, Goto T, Yamashita H, Nanno Y, Ishida J, et al. Indocyanine green (ICG) fluorography and digital subtraction angiography (DSA) of vessels supplying the remnant stomach that were performed during distal pancreatectomy in a patient with a history of distal gastrectomy: a case report. Clin J Gastroenterol 2021;14:1749-1755.